-transparent.png){kind=logo}
Antiserum to a synthetic peptide corresponding to the carboxyl-terminus of the human c-myc protein immunoprecipitated a 48,000-dalton protein from a number of normal and malignant human and mouse cells. The size of the protein is consistent with the potential coding region predicted from the c-myc nucleotide sequence, and is the same for malignant cells carrying either a rearranged or an unrearranged c-myc oncogene. Because c-myc transcripts are expressed at higher levels in malignant than in normal B cells, it appears that an increased level of the c-myc protein rather than a change in the gene product is the relevant factor in determining transformation.
Related Publications
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
June 1986,
British journal of cancer,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1991,
Histopathology,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1994,
Oncology,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
August 1985,
British journal of cancer,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1985,
Nature,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1990,
Journal of clinical pathology,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1997,
Current topics in microbiology and immunology,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
November 1988,
Cancer,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
March 1992,
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
A Giallongo, and
E Appella, and
R Ricciardi, and
G Rovera, and
C M Croce
January 1986,
British journal of cancer,
